Establishment Labs Holdings Inc. ESTA

Company Overview

Establishment Labs Holdings Inc. is a Costa Rica–based medical technology company focused on aesthetic and reconstructive plastic surgery products, primarily breast implants and related surgical technologies. The company operates within the global medical aesthetics and medical device industries and is best known for its Motiva-branded breast implant platform, which includes silicone gel-filled implants designed for breast augmentation and reconstruction procedures. Revenue is primarily generated through sales of breast implants, tissue expanders, and complementary surgical products sold to plastic surgeons, hospitals, and aesthetic clinics.

The company positions itself as a technology-focused innovator in breast aesthetics, emphasizing product safety, ergonomic design, and digital integration. A key differentiator has been the development of Motiva implants featuring proprietary technologies such as SmoothSilk surface technology and embedded RFID-enabled implant traceability in certain products. Establishment Labs was founded in 2004 by Juan José Chacón-Quirós and initially concentrated on international markets outside the United States. Over time, the company expanded globally and pursued regulatory approvals across Europe, Latin America, Asia-Pacific, and more recently the U.S. market through the FDA approval process for Motiva implants.